|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Athersys, Inc. and Fast Forward, LLC Enter Collaboration to Support Development of MultiStem to Treat Multiple Sclerosis
10/21/2011 10:27:57 AM
CLEVELAND and NEW YORK, Oct. 21, 2011 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) and Fast Forward, LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, announced today an alliance to fund the development of Athersys' MultiStem® adult stem cell platform for the treatment of Multiple Sclerosis (MS), including treatment of chronic progressive forms of the disease, with the goal of accelerating the clinical application of MultiStem for patients diagnosed with MS. Fast Forward will commit up to $640,000 to fund the advancement of the program to clinical development stage.
|
|
|
|
|
|
|
|
|
|
|